Eastman Chemical (EMN) Faces A Downgrade, Is It Still Below Fair Value?
JPMorgan’s decision to cut Eastman Chemical (EMN) to Neutral has pushed the stock back into focus for investors who are weighing recent share performance against the company’s cash generation and valuation signals.
Recent trading indicates that sentiment around Eastman Chemical is cooling. The share price is down 2.41% over the last day and 4.21% over the past month, with a 90 day share price decline of 9.14% contrasting with a 1 year total shareholder return of 6.8% as investors reassess both risk and the cash flow profile following JPMorgan’s downgrade.
See how Eastman Chemical compares with other materials stocks reassessed by the market and hand-picked for potential mispricing in our 33 high quality undervalued stocks.
Eastman Chemical now trades in the shadow of a fresh downgrade and a multi year share price drag, yet still generates solid cash flow and appears to trade at a discount. Does that balance of risk and reward still lean toward buyers?
Most Popular Narrative: 19% Undervalued
On the latest numbers, the most followed narrative pegs Eastman Chemical’s fair value at $77.19 against a last close of $62.33. This frames the current pullback as a valuation gap rather than a broken business case.
The numbers imply that the current valuation underestimates what Eastman Chemical could earn as circular earnings build, cost programs deliver the targeted $125 to $150 million in 2026, and projects like the ethylene to propylene conversion add incremental EBIT over time.
See why 23 investors see Eastman Chemical as 19% undervalued.
Result: Fair Value of $77.19 (UNDERVALUED)
Still, the story around Eastman Chemical can change quickly if weaker polyethylene pricing persists or if housing linked demand drags on high margin products.
Find out about the key risks to this Eastman Chemical narrative.
Next Steps
Does the current mood around Eastman Chemical feel a bit conflicted to you as well, with clear worries on one side and clear bright spots on the other? Step back from the noise, review the full picture, and weigh both the upsides and the red flags in the 5 key rewards and 2 important warning signs.
Looking for more ideas beyond Eastman Chemical?
Do not stop with a single ticker. Use the Simply Wall St screener to compare fresh ideas, filter risks quickly, and keep your watchlist one step ahead.
- Target reliable cash flows by reviewing companies that feature a 8 dividend fortresses.
- Hunt for mispriced quality by scanning the 20 high quality undiscovered gems that the wider market may be overlooking.
- Dial down portfolio stress by focusing on a 32 resilient stocks with low risk scores that screens for resilience and financial strength.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com